Clovis Oncology (CLVS)

Clovis Oncology (CLVS) – FDA

Nov 16, 2022 04:37 PM Clovis Oncology (CLVS) says FDA requested it to voluntarily revise label to limit the indication of Rubraca
Oct 27, 2022 05:05 PM Clovis Oncology (CLVS) Presents Data from TRITON3 Phase 3 Trial of Rubraca
Oct 17, 2022 05:26 AM
Oct 3, 2022 07:03 AM
Sep 13, 2022 08:01 AM
Sep 12, 2022 05:38 AM
Jun 14, 2022 02:02 PM
Jun 6, 2022 08:08 AM
Mar 31, 2022 06:15 AM
Mar 31, 2022 06:03 AM
Feb 25, 2022 08:09 AM
Dec 9, 2021 08:06 AM
Oct 7, 2021 09:04 AM
Jun 28, 2021 07:09 AM
Jun 14, 2021 09:41 AM
Mar 19, 2021 08:06 AM
Feb 17, 2021 10:01 AM
Feb 11, 2021 08:11 AM
Dec 21, 2020 08:02 AM
Sep 17, 2020 06:25 AM
Aug 27, 2020 06:08 AM
Aug 17, 2020 08:07 AM
Aug 5, 2020 08:15 AM
Jun 22, 2020 09:07 AM
Jun 17, 2020 08:08 AM
Jun 10, 2020 04:06 PM
May 28, 2020 08:04 AM
May 15, 2020 02:31 PM
Feb 3, 2020 06:12 AM
Jan 15, 2020 08:00 AM
Dec 16, 2019 08:35 AM
Nov 13, 2019 08:52 AM
May 20, 2019 04:09 PM
May 16, 2019 08:05 AM
Apr 12, 2019 04:21 PM
Apr 2, 2019 08:31 AM
Jan 24, 2019 12:29 PM
Dec 13, 2018 12:50 PM
Dec 4, 2018 07:37 AM
Oct 19, 2018 07:54 AM
Oct 19, 2018 06:06 AM
Oct 2, 2018 08:09 AM
Aug 8, 2018 08:07 AM
Jun 4, 2018 06:18 AM
Jun 4, 2018 06:09 AM
May 29, 2018 08:06 AM
Apr 6, 2018 01:40 PM
Apr 6, 2018 12:53 PM
Mar 23, 2018 09:04 AM
Mar 23, 2018 08:58 AM